摘要
Hepatocellular carcinoma (HCC) has a desmoplastic and hypoxic tumor microenvironment (TME), resulting in poor prognosis and treatment resistance. This study aimed to construct a novel prognostic classifier to investigate the degree of hypoxia and immune profiles in HCC. Patients with HCC from public databases were classified into three HIF-1a clusters according to 16 reported HIF-1a-related genes. Then, an HIF-1a score system was constructed based on nine overlapping differentially expressed genes (ODEGs) among various HIF-1a clusters. Then, an HIF-1a score system was constructed based on nine overlapping differentially expressed genes (ODEGs) among various HIF-1a cluster. Besides, oncologic pathways and immune infiltration profiles were also investigated among HCCs with different HIF-1a scores. The reliable predictive abilities of the HIF-1a score system for patients' survival were impressively suggested by the significant C-indexes and ROC analysis. All enrolled tumors were divided into high-, medium-, and low-HIF-1a score groups. Compared with the other two groups, the high HIF-1a score group exhibited highest enrichment of multiple oncogenic pathways, such as TNF-a signaling via NF-kB, IL6-JAK-STAT3 signaling, mTORC1 signaling, MYC signaling, Hedgehog signaling. Notably, higher HIF-1a scores correlated with advanced immunosuppressive TME. Besides, tumors with high HIF-1a scores represented high non-response rate to transcatheter arterial chemoembolization (TACE) and immune checkpoint blockade (ICB). In conclusion, we developed a novel HIF-1a score system to distinguish HCC with different degree of hypoxia and immune infiltration profiles.
学科与关键词
- Employing hypoxia characterization to predict tumour immune microenvironment, treatment sensitivity and prognosis in hepatocellular carcinomaZeng, Fanhong; Zhang, Yue; Han, Xu; Zeng, Min; Gao, Yi*; Weng, Jun*Computational and Structural Biotechnology Journal, 2021, 19: 2775-2789.被引 16
- Ahypoxia-related signature enhances the prediction of the prognosis in hepatocellular carcinoma patients and correlates with sorafenib treatment responseJiang, Hong-Ye; Ning, Gang; Wang, Yen-Sheng; Lv, Wei-Biao*American Journal of Translational Research, 2020, 12(12): 7762-7781.被引 14
- A Comprehensive Prognostic and Immunological Analysis of a New Three-Gene Signature in Hepatocellular CarcinomaLiu, Jun; Lu, Jianjun; Li, Wenli*2021, 2021: 5546032.被引 8
